Established in 2010, this manufacturer specializes in oral pharmaceutical formulations, granule sachets, and parenteral products. As a CTD dossier owner and manufacturer, it holds WHO-GMP certification, ensuring compliance with international quality standards. The manufacturing facility aligns with US-FDA and PIC/S guidelines and has received approvals from regulatory authorities in countries such as Tanzania, Malawi, Ghana, Kenya, Uganda, Ethiopia, Saudi Arabia, Cambodia, and Zimbabwe. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in multiple countries worldwide. With a focus on pain management and de-addiction medicines, the manufacturer is committed to delivering high-quality healthcare solutions.